News

Materials, Structures and Manufacturing Group announce new post-doc and PhD positions

05 Jan 2021

The Materials, Structures and Manufacturing Group, led by Professor Peter Lee, UCL at the Research Complex at Harwell have announced a number of positions now available for application. The Group’s  research focuses on the X-ray imaging and computational simulation of materials at a microstructural level and as part of two exciting aligned projects, two Post-Doc/PDRF…

Read More

Winner of Sir John Meurig Thomas Catalysis Medal for 2020 announced

21 Dec 2020

The UK Catalysis Hub have named Professor Adrian Mulholland from the University of Bristol as winner of the Sir John Meurig Thomas Catalysis Medal at the UK Catalysis Hub Winter Conference on the 7th of December 2020. Prof. Adrian Mulholland was selected from the nominations for top mid-career scientists working in the United Kingdom to…

Read More

CZI grant awarded to UCL and ESRF project for the development of HiP-CT imaging

16 Dec 2020

Professor Peter Lee, along with Professor Rebecca Shipley and Professor Paul Tafforeau, has been awarded a £750,000 Chan Zuckerberg Initiative (CZI) grant as part of a world-wide call to advance deep tissue imaging. The award-winning team leaders from UCL and ESRF have developed a project, titled ‘Anatomical to cellular synchrotron imaging of the whole human…

Read More

“As a global community, we need to have resilient technologies and policies to help us cope in the future”: An interview with Sir Richard Catlow

15 Dec 2020

Sir Richard Catlow is one of the world’s leading chemists, honoured this summer with a knighthood in the Queen’s Birthday Honours in recognition of his many services to leadership in science and research. He holds concurrent positions as Professor of Computational and Materials Chemistry at UCL and Professor of Catalytic and Computational Chemistry at Cardiff…

Read More

Final week to submit funding applications for COVID-19 research

08 Dec 2020

This week marks the final week for applications to be submitted for the UKRI’s open funding opportunity for research and innovation proposals that address problems related to COVID-19. The UKRI has provided a list of priority areas for funding to increase an applicant’s chances of submitting a successful entry. If you have an existing UKRI…

Read More

Webinar offering ‘new perspectives on COVID-19’ to be held

30 Nov 2020

Academia Europea has announced that a webinar offering new perspectives on COVID-19 will take place in the New Year. The webinar will involve 6 presentations by members of Academia Europaea, who have all recently published papers on various biomedical aspects of COVID-19. The webinar will take place on 26th January 2021 at 1pm GMT time….

Read More

British Science Association and AAPG launch enquiry into equity in UK STEM workforce

13 Nov 2020

The British Science Association has announced that the All-Party Parliamentary Group (APPG) on Diversity and Inclusion in Science, Technology, Engineering and Maths (STEM) has launched an inquiry into Equity for the STEM workforce throughout the UK. This enquiry aims to focus on how the Government and organisations employing STEM workers are helping to create a diverse and…

Read More

Congratulations to Sir Richard Catlow

12 Oct 2020

The Research Complex at Harwell takes great pleasure in wishing Professor Richard Catlow congratulations on being awarded a Knighthood in the Queens 2020 Birthday Honours List.   Sir Charles Richard Arthur Catlow FRS FRSC FInstP  is a chemist who holds concurrent positions as Professor of Computational and Materials Chemistry at UCL and Professor of Catalytic…

Read More

GyreOx, a group working at the Research Complex, announces seed funding

17 Mar 2020

GyreOx announces seed funding to develop novel therapeutics targeting intracellular proteins implicated in cancer and autoimmune diseases 11 March 2020 – GyreOx Therapeutics (GyreOx), developing its novel MACRO platform, announces financial backing today from UKI2S and LifeArc. Developing complex molecules able to target intracellular interactions, the company will develop therapy for cancer and autoimmune diseases…

Read More